First human tests for groundbreaking malaria vaccine
NCT ID NCT02658253
Summary
This study tested the safety and immune response of a new vaccine designed to protect pregnant women from placental malaria. It involved 68 healthy adult women from France and Burkina Faso who received three doses of the experimental vaccine. The main goal was to check for side effects and see if the vaccine triggered a protective immune response.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALARIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CIC 1417
Paris, 75679, France
-
CNRFP
Ouagadougou, BP 2208, Burkina Faso
Conditions
Explore the condition pages connected to this study.